Page last updated: 2024-09-05

iclaprim and telavancin

iclaprim has been researched along with telavancin in 5 studies

Compound Research Comparison

Studies (iclaprim)	Trials (iclaprim)	Recent Studies (post-2010) (iclaprim)	Studies (telavancin)	Trials (telavancin)	Recent Studies (post-2010) (telavancin)
45	7	16	245	29	139

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Micek, ST; Neuner, EA; Ritchie, DJ	1
Cabeza, J; Carrasco, C; Gutierrez, J; Sorlozano, A; Villegas, E	1
Cattoir, V; Daurel, C	1
Kollef, MH	1

Reviews

3 review(s) available for iclaprim and telavancin

Article	Year
New antibiotics for healthcare-associated pneumonia. Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin	2009
[Update on antimicrobial chemotherapy]. Medecine et maladies infectieuses, 2010, Volume: 40, Issue:3 Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline	2010
New antimicrobial agents for methicillin-resistant Staphylococcus aureus. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2009, Volume: 11, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Glycopeptides; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pyrimidines; Staphylococcal Infections; Teicoplanin	2009

Other Studies

2 other study(ies) available for iclaprim and telavancin

Article	Year
Regulatory watch: Non-inferiority-trial discussions impact new drug applications. Nature reviews. Drug discovery, 2009, Volume: 8, Issue:1 Topics: Aminoglycosides; Anti-Infective Agents; Drug Approval; Drug Evaluation; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Therapeutic Equivalency; United States; United States Food and Drug Administration	2009
Antimicrobial development in the era of emerging resistance. Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:8 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Skin Diseases, Bacterial; Skin Diseases, Viral; Teicoplanin; United States; United States Food and Drug Administration	2009

Article

Year

Regulatory watch: Non-inferiority-trial discussions impact new drug applications.

Nature reviews. Drug discovery, 2009, Volume: 8, Issue:1

Topics: Aminoglycosides; Anti-Infective Agents; Drug Approval; Drug Evaluation; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Therapeutic Equivalency; United States; United States Food and Drug Administration

2009

Antimicrobial development in the era of emerging resistance.

Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:8

Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Skin Diseases, Bacterial; Skin Diseases, Viral; Teicoplanin; United States; United States Food and Drug Administration

2009